Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review

References

• SessaMRossiCMascoloASuspected adverse reactions to contrast media in Campania Region (Italy): results from 14 years of post-marketing surveillanceExpert Opin Drug Saf20151491341135126156557
   PubMed Web of Science ®Google Scholar
• LusicHGrinstaffMWX-ray computed tomography contrast agentsChem Rev201311331641166623210836
   PubMed Web of Science ®Google Scholar
• LencioniRChiesura-CoronaMDrudiFMMoranaGFeltrinGPGavelliGClinical experimentation with contrast media in ItalyRadiol Med2001101310911011402946
   PubMedGoogle Scholar
• Gazzetta Ufficiale; Repubblica Italiana [Italian Official Journal; Italian Republic]Decreto Legislativo 19 febbraio 2014, n. 17 Attuazione della direttiva 2011/62/UE, che modifica la direttiva 2001/83/CE, recante un codice comunitario relativo ai medicinali per uso umano [Legislative Decree 19 February 2014, n. 17 Implementation of Directive 2011/62/EU amending Directive 2001/83/EC on the Community code relating to medicinal products for human use] Available from: http://www.gazzettaufficiale.it/eli/id/2014/03/07/14G00027/sgAccessed October 7, 2017 Italian
   Google Scholar
• SessaMMascoloAAndersenMPEffect of chronic kidney diseases on mortality among digoxin users treated for non-valvular atrial fibrillation: a nationwide register-based retrospective cohort studyPLoS One2016117e016033727467520
   PubMed Web of Science ®Google Scholar
• SessaMRafanielloCSportielloLCampania region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: a pilot study on psychotropic drugsExpert Opin Drug Saf201615Suppl 291527875917
   PubMed Web of Science ®Google Scholar
• SessaMRossiCRafanielloCCampania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactionsExpert Opin Drug Saf201615Suppl 2515927855534
   PubMed Web of Science ®Google Scholar
• ScavoneCSessaMScavoneCNew era in treatment options of chronic hepatitis C: focus on safety of new direct-acting antivirals (DAAs)Expert Opin Drug Saf201615Suppl 28510027875916
   PubMed Web of Science ®Google Scholar
• ParrettaERafanielloCMagroLImprovement of patient adverse drug reaction reporting through a community pharmacist-based intervention in the Campania region of ItalyExpert Opin Drug Saf201413Suppl 1S21S2925171156
   PubMed Web of Science ®Google Scholar
• RafanielloCFerrajoloCSulloMGRisk of gastrointestinal complications associated to NSAIDs, low-dose aspirin and their combinations: results of a pharmacovigilance reporting systemPharmacol Res201610410811426739516
   PubMed Web of Science ®Google Scholar
• MascoloARafanielloCSportielloLDipeptidyl peptidase (DPP)-4 inhibitor-induced arthritis/arthralgia: a review of clinical casesDrug Saf201639540140726873369
   PubMed Web of Science ®Google Scholar
• SessaMSulloMGMascoloAA case of figurate urticaria by etanerceptJ Pharmacol Pharmacother20167210610827440958
   PubMedGoogle Scholar
• MascoloASessaMScavoneCNew and old roles of the peripheral and brain renin-angiotensin-aldosterone system (RAAS): focus on cardiovascular and neurological diseasesInt J Cardiol201722773474227823897
   PubMed Web of Science ®Google Scholar
• BrockowKImmediate and delayed cutaneous reactions to radiocontrast mediaChem Immunol Allergy20129718019022613862
   PubMedGoogle Scholar
• BergKJNephrotoxicity related to contrast mediaScand J Urol Nephrol20003431732211186471
   PubMed Web of Science ®Google Scholar
• NamasivayamSKalraMKTorresWESmallWCAdverse reactions to intravenous iodinated contrast media: an updateCurr Probl Diagn Radiol200635416416916814003
   PubMedGoogle Scholar
• GeenenRWFKingmaHJvan der MolenAJContrast-induced nephropathy: pharmacology, pathophysiology and preventionInsights Imaging2013481182024092564
   PubMedGoogle Scholar
• ThomsenHSMorcosSKBarrettBJContrast-induced nephropathy: the wheel has turned 360 degreesActa Radiol200849664665718568557
   PubMed Web of Science ®Google Scholar
• SkrboAZulicIHadzicSGaonIDAnatomsko-terapijsko-kemijska klasifikacija lijekova. The article is in Croatian [Anatomic-therapeutic-chemical classification of drugs]Med Arh1999535760 Croatian10870628
   PubMedGoogle Scholar
• MerlinTWestonATooherRExtending an evidence hierarchy to include topics other than treatment: revising the Australian “levels of evidence”BMC Med Res Methodol200993419519887
   PubMed Web of Science ®Google Scholar
• PattiGRicottiniENuscaAShort-term, high-dose Atorvastatin pretreatment to prevent contrast-induced nephropathy in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the ARMYDA-CIN [atorvastatin for reduction of myocardial damage during angioplasty – contrast-induced nephropathy] trial)Am J Cardiol20111081721529740
   PubMed Web of Science ®Google Scholar
• QuintavalleCFioreDDe MiccoFImpact of a high loading dose of atorvastatin on contrast-induced acute kidney injuryCirculation2012126253008301623147173
   PubMed Web of Science ®Google Scholar
• LeonciniMTosoAMaioliMTropeanoFVillaniSBellandiFEarly high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: results from the PRATO-ACS Study (Protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome)J Am Coll Cardiol2014631717924076283
   PubMed Web of Science ®Google Scholar
• TosoALeonciniMMaioliMRelationship between inflammation and benefits of early high-dose rosuvastatin on contrast-induced nephropathy in patients with acute coronary syndrome: the pathophysiological link in the PRATO-ACS study (Protective effect of rosuvastatin and antiplatelet therapy on contrast-induced acute kidney injury and myocardial damage in patients with acute coronary syndrome undergoing coronary intervention)JACC Cardiovasc Interv20147121421142925523533
   PubMed Web of Science ®Google Scholar
• TropeanoFLeonciniMTosoAImpact of Rosuvastatin in contrast-induced acute kidney injury in the elderly: post hoc analysis of the PRATO-ACS trialJ Cardiovasc Pharmacol Ther201621215916626307206
   PubMed Web of Science ®Google Scholar
• TosoAMaioliMLeonciniMUsefulness of atorvastatin (80 mg) in prevention of contrast-induced nephropathy in patients with chronic renal diseaseAm J Cardiol2010105328829220102936
   PubMed Web of Science ®Google Scholar
• GiacoppoDCapodannoDCapranzanoPArutaPTamburinoCMeta-analysis of randomized controlled trials of preprocedural statin administration for reducing contrast-induced acute kidney injury in patients undergoing coronary catheterizationAm J Cardiol2014114454154825001154
   PubMed Web of Science ®Google Scholar
• BarbieriLVerdoiaMSchafferANardinMMarinoPDe LucaGThe role of statins in the prevention of contrast induced nephropathy: a meta-analysis of 8 randomized trialsJ Thromb Thrombolysis201438449350224705677
   PubMed Web of Science ®Google Scholar
• MarenziGCosentinoNWerbaJPTedescoCCVegliaFBartorelliALA meta-analysis of randomized controlled trials on statins for the prevention of contrast-induced acute kidney injury in patients with and without acute coronary syndromesInt J Cardiol2015183475325662053
   PubMed Web of Science ®Google Scholar
• CalabroPBianchiRCrisciMUse and efficacy of saline hydration and N-acetyl cysteine to prevent contrast-induced nephropathy in low-risk populations undergoing coronary artery angiographyIntern Emerg Med20116650350721279477
   PubMed Web of Science ®Google Scholar
• BriguoriCManganelliFScarpatoPAcetylcysteine and contrast agent-associated nephrotoxicityJ Am Coll Cardiol20024029830312106935
   PubMed Web of Science ®Google Scholar
• ValleroACesanoGPozzatoMNefropatia indotta da mezzi di contrasto: nessun vantaggio dall’uso in profilassi dell’N-acetilcisteina (NAC) [Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)]G Ital Nefrol200219529533 Italian12439841
   PubMedGoogle Scholar
• AlessandriNLanziLGaranteCMPrevention of acute renal failure post-contrast imaging in cardiology: a randomized studyEur Rev Med Pharmacol Sci201317Suppl 1132123436661
   PubMed Web of Science ®Google Scholar
• MarenziGAssanelliEMaranaIN-acetylcysteine and contrast-induced nephropathy in primary angioplastyN Engl J Med2006354262773278216807414
   PubMed Web of Science ®Google Scholar
• BriguoriCColomboAViolanteAStandard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicityEur Heart J200425320621114972420
   PubMed Web of Science ®Google Scholar
• BriguoriCColomboAAiroldiFN-Acetylcysteine versus fenoldopam mesylate to prevent contrast agent-associated nephrotoxicityJ Am Coll Cardiol200444476276515312855
   PubMed Web of Science ®Google Scholar
• BriguoriCAiroldiFD’AndreaDRenal insufficiency following contrast media administration trial (REMEDIAL): a randomized comparison of 3 preventive strategiesCirculation20071151211121717309916
   PubMed Web of Science ®Google Scholar
• BriguoriCColomboAAiroldiFNephrotoxicity of low-osmolality versus iso-osmolality contrast agents: impact of N-acetylcysteineKidney Int20056852250225516221226
   PubMed Web of Science ®Google Scholar
• RussoDTestaADella VolpeLSansoneGRandomised prospective study on renal effects of two different contrast media in humans: protective role of a calcium channel blockerNephron19905532542572370924
   PubMed Web of Science ®Google Scholar
• MaioliMTosoALeonciniMMichelettiCBellandiFEffects of hydration in contrast-induced acute kidney injury after primary angioplasty: a randomized, controlled trialCirc Cardiovasc Interv20114545646221972403
   PubMed Web of Science ®Google Scholar
• La MannaGPancaldiLGCapecchiARisk for contrast nephropathy in patients undergoing coronarographyArtif Organs2010346E193E19920482707
   PubMed Web of Science ®Google Scholar
• MarenziGFerrariCMaranaIPrevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (induced diuresis with matched hydration compared to standard hydration for contrast induced nephropathy prevention) trialJACC Cardiovasc Interv201251909722230154
   PubMed Web of Science ®Google Scholar
• BriguoriCViscontiGDonahueMRenalGuard system in high-risk patients for contrast-induced acute kidney injuryAm Heart J2016173677626920598
   PubMed Web of Science ®Google Scholar
• La MannaGPancaldiLDalmastriVPost-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiencyIn Vivo200822112312918396794
   PubMed Web of Science ®Google Scholar
• GuastoniCBellottiNPolettiFContinuous venovenous hemofiltration after coronary procedures for the prevention of contrast-induced acute kidney injury in patients with severe chronic renal failureAm J Cardiol2014113458859224321895
   PubMed Web of Science ®Google Scholar
• MarenziGMaranaILauriGThe prevention of radiocontrast-agent-induced nephropathy by hemofiltrationN Engl J Med2003349141333134014523141
   PubMed Web of Science ®Google Scholar
• MarenziGBartorelliALHemofiltration in the prevention of radiocontrast agent induced nephropathyMinerva Anestesiol200470418919115173694
   PubMedGoogle Scholar
• MarenziGLauriGCampodonicoJComparison of two hemofiltration protocols for prevention of contrast-induced nephropathy in high-risk patientsAm J Med2006119215516216443418
   PubMed Web of Science ®Google Scholar
• BriguoriCViscontiGFocaccioAREMEDIAL II InvestigatorsRenal insufficiency after contrast media administration trial II (REMEDIAL II): renalguard system in high-risk patients for contrast-induced acute kidney injuryCirculation2011124111260126921844075
   PubMed Web of Science ®Google Scholar
• MarenziGBartorelliALLauriGContinuous veno-venous hemofiltration for the treatment of contrast-induced acute renal failure after percutaneous coronary interventionsCatheter Cardiovasc Interv200358596412508197
   PubMed Web of Science ®Google Scholar
• AndoGCorteseBFrigoliEAcute kidney injury after percutaneous coronary intervention: rationale of the AKI-MATRIX (acute kidney injury-minimizing adverse hemorrhagic events by TRansradial access site and systemic implementation of angioX) sub-studyCatheter Cardiovasc Interv201586595095725854692
   PubMed Web of Science ®Google Scholar
• BianchiPCarboniGPesceGCardiac catheterization and postoperative acute kidney failure in congenital heart pediatric patientsAnesth Analg2013117245546123780421
   PubMed Web of Science ®Google Scholar
• MarenziGAssanelliECampodonicoJContrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortalityAnn Intern Med2009150317017719189906
   PubMed Web of Science ®Google Scholar
• AndoGde GregorioCMorabitoGTrioOSaporitoFOretoGRenal function-adjusted contrast volume redefines the baseline estimation of contrast-induced acute kidney injury risk in patients undergoing primary percutaneous coronary interventionCirc Cardiovasc Interv20147446547225027519
   PubMed Web of Science ®Google Scholar
• RanucciMBallottaAKunklAInfluence of the timing of cardiac catheterization and the amount of contrast media on acute renal failure after cardiac surgeryAm J Cardiol200810181112111818394443
   PubMed Web of Science ®Google Scholar
• MarenziGDe MetrioMRubinoMAcute hyperglycemia and contrast-induced nephropathy in primary percutaneous coronary interventionAm Heart J201016061170117721146674
   PubMed Web of Science ®Google Scholar
• BarbieriLVerdoiaMSchafferAElevated homocysteine and the risk of contrast-induced nephropathy: a cohort studyAngiology201566433333824830422
   PubMed Web of Science ®Google Scholar
• MorabitoSPistolesiVBenedettiGIncidence of contrast-induced acute kidney injury associated with diagnostic or interventional coronary angiographyJ Nephrol20122561098110722383347
   PubMed Web of Science ®Google Scholar
• LucreziottiSCentolaMSalerno-UriarteDFemale gender and contrast-induced nephropathy in primary percutaneous intervention for ST-segment elevation myocardial infarctionInt J Cardiol20141741374224698233
   PubMed Web of Science ®Google Scholar
• DonahueMViscontiGFocaccioAAcute kidney injury in patients with chronic kidney disease undergoing internal carotid artery stent implantationJACC Cardiovasc Interv20158111506151426298226
   PubMed Web of Science ®Google Scholar
• RanucciMBallottaAAgnelliBSurgical and Clinical Outcome Research (SCORE) GroupAcute kidney injury in patients undergoing cardiac surgery and coronary angiography on the same dayAnn Thorac Surg201395251351923201106
   PubMed Web of Science ®Google Scholar
• MarenziGLauriGAssanelliEContrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarctionJ Am Coll Cardiol2004441780178515519007
   PubMed Web of Science ®Google Scholar
• MarracciniPBianchiMFommeiEContrast medium nephrotoxicity after renal artery and coronary angioplastyActa Radiol201051446246620192893
   PubMed Web of Science ®Google Scholar
• CrimiGLeonardiSCostaFIncidence, prognostic impact, and optimal definition of contrast-induced acute kidney injury in consecutive patients with stable or unstable coronary artery disease undergoing percutaneous coronary intervention. Insights from the all-comer PRODIGY trialCatheter Cardiovasc Interv2015861E19E2725703119
   PubMed Web of Science ®Google Scholar
• RussoDMinutoloRCianciarusoBMemoliBConteGDe NicolaLEarly effects of contrast media on renal hemodynamics and tubular function in chronic renal failureJ Am Soc Nephrol199565145114588589322
   PubMed Web of Science ®Google Scholar
• PredaLAgazziARaimondiSEffect on renal function of an iso-osmolar contrast agent in patients with monoclonal gammopathiesEur Radiol2011211636920680288
   PubMed Web of Science ®Google Scholar
• ValenteSLazzeriCGiglioliCContrast-induced nephropathy in urgent coronary interventionsJ Cardiovasc Med (Hagerstown)200671073774117001234
   PubMed Web of Science ®Google Scholar
• MaioliMTosoALeonciniMGallopinMMusilliNBellandiFPersistent renal damage after contrast-induced acute kidney injury: incidence, evolution, risk factors, and prognosisCirculation20121253099310722592896
   PubMed Web of Science ®Google Scholar
• BudanoCLevisMD’AmicoMImpact of contrast-induced acute kidney injury definition on clinical outcomesAm Heart J2011161596397121570530
   PubMed Web of Science ®Google Scholar
• NarulaAMehranRWeiszGContrast-induced acute kidney injury after primary percutaneous coronary intervention: results from the HORIZONS-AMI substudyEur Heart J201435231533154024603308
   PubMed Web of Science ®Google Scholar
• CentolaMLucreziottiSSalerno-UriarteDA comparison between two different definitions of contrast-induced acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary interventionInt J Cardiol20162104926921538
   PubMed Web of Science ®Google Scholar
• QuintavalleCAnselmiCVDe MiccoFNeutrophil gelatinase-associated lipocalin and contrast-induced acute kidney injuryCirc Cardiovasc Interv20158e00267326333343
   PubMed Web of Science ®Google Scholar
• BriguoriCViscontiGRiveraNVCystatin C and contrast-induced acute kidney injuryCirculation2010121192117212220439784
   PubMed Web of Science ®Google Scholar
• RibichiniFGambaroGGrazianiMSComparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventionsClin Chem201258245846422166252
   PubMed Web of Science ®Google Scholar
• LimbrunoUPicchiAMicheliARefining the assessment of contrast-induced acute kidney injury: the load-to-damage relationshipJ Cardiovasc Med (Hagerstown)201415758759423811842
   PubMed Web of Science ®Google Scholar
• MaioliMTosoAGallopinMPreprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and interventionJ Cardiovasc Med (Hagerstown)20101144444920164783
   PubMed Web of Science ®Google Scholar
• RibichiniFGrazianiMGambaroGEarly creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiographyAm J Med2010123875576320670731
   PubMed Web of Science ®Google Scholar
• BologneseLFalsiniGSchwenkeCImpact of iso-osmolar versus low-osmolar contrast agents on contrast-induced nephropathy and tissue reperfusion in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (from the Contrast Media and Nephrotoxicity Following Primary Angioplasty for Acute Myocardial Infarction [CONTRAST-AMI] Trial)Am J Cardiol20121091677421943940
   PubMed Web of Science ®Google Scholar
• CarraroMMalalanFAntonioneREffects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: a double-blind, randomized clinical trialEur Radiol1998811441479442148
   PubMed Web of Science ®Google Scholar
• Biondi-ZoccaiGLotrionteMThomsenHSNephropathy after administration of iso-osmolar and low-osmolar contrast media: evidence from a network meta-analysisInt J Cardiol2014172237538024502883
   PubMed Web of Science ®Google Scholar
• SimonettiGGuazzaroniMCarpaneseLCanalisGCUrigoFA double-blind comparative study of the safety and efficacy of iomeprol in renal intra-arterial digital subtraction angiographyEur J Radiol199418Suppl 1S73S768020522
   PubMed Web of Science ®Google Scholar
• LorussoVTaroniPAlvinoSSpinazziAPharmacokinetics and safety of iomeprol in healthy volunteers and in patients with renal impairment or end-stage renal disease requiring hemodialysisInvest Radiol200136630931611410750
   PubMed Web of Science ®Google Scholar
• BruderOSchneiderSPilzG2015 update on acute adverse reactions to gadolinium based contrast agents in cardiovascular MR. Large multi-national and multi-ethnical population experience with 37788 patients from the EuroCMR RegistryJ Cardiovasc Magn Reson2015175826170152
   PubMed Web of Science ®Google Scholar
• LevinDCAbramsHLCastaneda-ZunigaWRLessons from history. Why radiologists lost coronary angiography and what can be done to prevent future similar lossesInvest Radiol1994294804848034457
   PubMed Web of Science ®Google Scholar
• ThieseMSObservational and interventional study design types; an overviewBiochem Medica (Zagreb)2014242199210
   PubMed Web of Science ®Google Scholar
• De LucaLLucciDBovenziFPerrone FilardiPSantoroGSchweigerC5°Censimento delle strutture cardiologiche in Italia [Fifth Census of cardiological structures in Italy]G Ital Cardiol200810Suppl 3–65S83S Italian
   Google Scholar
• VercellinoMBezanteGPBalbiMContrast medium induced nephropathy: new insights into prevention and risk managementCardiovasc Hematol Agents Med Chem20097216618019355877
   PubMedGoogle Scholar
• DavenportMSCohanRHEllisJHContrast media controversies in 2015: imaging patients with renal impairment or risk of contrast reactionAJR Am J Roentgenol201520461174118125730301
   PubMed Web of Science ®Google Scholar
• SafirsteinRAndradeLVieiraJMAcetylcysteine and nephrotoxic effects of radiographic contrast agents – a new use for an old drugN Engl J Med2000343321021210900284
   PubMed Web of Science ®Google Scholar
• StaculFAdamABeckerCRCIN Consensus Working PanelStrategies to reduce the risk of contrast-induced nephropathyAm J Cardiol2006986A59K77K
   PubMed Web of Science ®Google Scholar
• KaoLSTysonJEBlakelyMLLallyKPClinical research methodology I: introduction to randomized trialsJ Am Coll Surg200820636136918222393
   PubMed Web of Science ®Google Scholar